Pharmacy Clinical Management. ICS Camp de Tarragona

Pharmacy Clinical Management. ICS Camp de Tarragona

  • MISSION, VISION, VALUES
  • SERVICES PORTFOLIO
  • TEAM
  • PUBLICATIONS
  • CONTACT

MISSION

Contribute to the improvement of the patient’s health through pharmaceutical care that adds healthcare value and promotes and enables the effective, safe, and efficient use of medicines in a framework of integrated, integrated, and continuous care.

VISION

To be a leading, innovative and prestigious healthcare service that ensures that patients have an optimal, safe, and effective pharmacotherapeutic profile with their pharmacotherapeutic objectives. The service must contribute to obtaining a health system of the highest quality.

 VALUES

These are the areas in which pharmaceutical care for patients must be excellent to create value in their relationship with healthcare professionals and improve the effectiveness of their actions. They represent the main areas in which to focus efforts to achieve a vision.

  • Patient-oriented activity
  • Results in health and quality of life
  • Professional excellence: leadership, visibility, and recognition in pharmacotherapy
  • Efficiency in the management of pharmacotherapeutic resources
  • Commitment to change and innovation.
  • Acquisition of medicines after selection in accordance with the criteria established by the territory itself.

 

  • Custody, conservation, supply and dispensing of medicines necessary for the development of hospital activities and extra-hospital treatments that require surveillance, supervision and control.

 

  • Development of master formulas, office preparations, dangerous drugs, intravenous mixtures and other preparations necessary for in-hospital or out-of-hospital care that require preparation, monitoring, supervision and control.

 

  • Development and implementation of guidelines and therapeutic protocols for application in the hospital, social health and primary care.

 

  • Research in the field of medicine and participation in clinical trials, as well as the custody and preparation of products in the clinical research phase.Elaboration and development of safety and pharmacovigilance programs in the Camp de Tarragona.

 

  • Comprehensive and integrated pharmaceutical care in hospitalized, outpatient, social and primary care patients. Ensuring continuity of care.

 

  • Implementation of a quality assurance system in accordance with standard working procedures.

 

  • Economic management of the medicine area at the ICS Camp in Tarragona.

 

  • FIR training, supervised internships for undergraduate students in Pharmacy and intermediate-level pharmacy technicians. Teaching clinical pharmacology to medical and nursing students at the URV, also integrating internal medical students and final degree projects. Offer of internships for biomedical engineering.

Laura Canadell Vilarrasa

PhD from Rovira i Virgili University.

Clinical Director. Coordination of Pharmacy Services HJ23, Pius Valls, Francolí Sociosanitary Hospital, Mas Enric Prison and ICS Camp de Tarragona Primary Care Pharmacy. Responsible for the safety and quality of pharmacotherapy

 

FARMÀCIA HJ23

Maria Vuelta Arce

Degree in Pharmacy. Complutense University of Madrid.

Specialist doctor. Pharmaceutical care for onco-hematological patients. Hazardous Drug Processing Area. Tutor of residents in training.

Sonia Jornet Montaña

Degree in Pharmacy. Barcelona University.

Specialist doctor. Pharmaco-economic management area. Outpatient pharmaceutical care coordinator.

Àngels Roch Ventura

Degree in Pharmacy. University of Valencia.

Specialist doctor. Area of pharmaceutical care for admitted patients and pharmaceutical care for HCV patients. Responsible for the clinical trials area

Marta Martín Marqués

Degree in Pharmacy. Barcelona University.

Specialist doctor. Pediatric patient care area. Area for the elaboration of master formulas and office preparations.

María Mendoza Aguilera

Degree in Pharmacy. University of Valencia.

Specialist doctor. Area of pharmaceutical care for admitted patients and pharmaceutical care for HIV patients. Responsible for medication conciliation.

Pilar Ana López Broseta

Degree in Pharmacy. University of Valencia.

Specialist doctor. Area of pharmaceutical care in immunomediated inflammatory diseases. Responsible for the pharmacokinetics of selective immunosuppressants.

Erika Esteve Pitarch

Degree in Pharmacy. University of Valencia.

Specialist doctor. Pharmaceutical care area for critically ill patients. Responsible for parenteral nutrition.

Josefa Boada Hernández

Degree in Pharmacy. University of Valencia.

Specialist doctor. Pharmaceutical care area for pediatric patients. Area of elaboration of masterful formulas.

Fran Cabrera Díez

Degree in Pharmacy. University of Granada.

Specialist doctor. Pharmaceutical care for onco-hematological patients.

 

PHARMACY PRIMARY CARE ICS CAMP DE TARRAGONA

Ferran Bejarano Romero

Degree in Medicine. Barcelona University.

Specialist doctor. Camp de Tarragona Primary Care Pharmacy Coordinator.

Cecilia Campabadal Prats

Degree in Pharmacy. University of Barcelona

Specialist doctor. Primary care pharmacy Camp de Tarragona. Responsible AF patient residences.

Clara Salom Garrigues

Degree in Pharmacy. University of Valencia.

Specialist doctor. Primary care pharmacy Camp de Tarragona. Responsible for AF patients ATDOM

Lidon Castillo Palomares

Degree in Pharmacy. University of Valencia.

Specialist doctor. Primary care pharmacy Camp de Tarragona. Pharmaceutical care Mas d’Enric Penitentiary Center.

 

FARMÀCIA PIUS VALLS-AP

Josep Torrent Pou

Degree in Pharmacy. Barcelona University.

Specialist doctor. Head of Pharmacy Service at Puis Valls Hospital.

Silvia Conde Giner

Degree in Pharmacy. University of Valencia.

Specialist doctor. Pharmaceutical care Primary care pharmacy Camp de Tarragona. Pharmaceutical care Hospital Puis Valls.

Ángel Marcos Fendian

Degree in Pharmacy. University of Valencia.

Specialist doctor. Pharmaceutical care Primary care pharmacy Camp de Tarragona. Pharmaceutical care Hospital Puis Valls.

 

FARMACIA HSS Francolí

Loreto Veciana Balsebre

Degree in Pharmacy. Barcelona University

Institutionalized patient pharmaceutical care. Francolí Sociosanitary Hospital.

 

RESIDENTS FIR

Jorge del Estal Jiménez

Graduate in Pharmacy. University of Salamanca.

Resident Internal Pharmacist. R4

Alejandro Sanjuan Belda

Graduate in Pharmacy. University of Valencia.

Resident Internal Pharmacist. R2

Ignasi Sacanella Anglès

Graduate in Pharmacy. Barcelona University.

Resident Internal Pharmacist. R1

ARTICLES

Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic.

A Rodríguez, G Moreno, J Gómez, R Carbonell, E Picó-Plana, C Benavent Bofill, R Sánchez Parrilla, S Trefler, E Esteve PitarchL Canadell, X Teixido, L Claverias , M Bodí , por el HJ23-COVID-19 working group. Med Intensiva. 2020 Dec;44(9):525-533. doi: 10.1016/j.medin.2020.05.018. Epub 2020 Jun 19.

 

Cost-effectiveness of brief structured interventions to discontinue long-term benzodiazepine use: an economic analysis alongside a randomised controlled trial.

Trépel D, Ali S, Gilbody S, Leiva A, Mcmillan D, Bejarano F, Sempere E, Vicens C. HRB Open Res. 2020 Jun 3;3:33. doi: 10.12688/hrbopenres.13049.1. PMID: 32743341; PMCID: PMC7372528.

 

Comprehensive tackling to the safe handling of hazardous drugs: a multidisciplinary approach to clinical practice.

Vuelta-Arce M, Chiapella-Micó C, Mestre-Prad MT, Teixidó-Huerta X, Del Estal-Jiménez J, Rodríguez-Gías E, Guinovart-Alemany M. Int J Occup Med Environ Health. 2020 Sep 17;33(5):621-634. doi: 10.13075/ijomeh.1896.01534. Epub 2020 Jul 27. PMID: 32716012.

 

Intervention to reduce benzodiazepine prescriptions in primary care, study protocol of a hybrid type 1 cluster randomised controlled trial: the BENZORED study.

Vicens C, Leiva A, Bejarano F, Sempere E, Rodríguez-Rincón RM, Fiol F, Mengual M, Ajenjo A, Do Pazo F, Mateu C, Folch S, Alegret S, Coll JM, Martín-Rabadán M, Socias I. BMJ Open. 2019 Jan 30;9(1):e022046. doi: 10.1136/bmjopen-2018-022046. PMID: 30705235; PMCID: PMC6359733.

 

In vitro evaluation of aerosol delivery of aztreonam lysine (AZLI): an adult mechanical ventilation model.

Rodríguez A, Cabrera M, Reyes LF, Bodí M, Trefler S, Canadell L, Barahona D,Ehrmann S, Martin-Loeches ,Restrepo MI, Vecellio L. Expert Opin Drug Deliv. 2017 Dec;14(12):1447-1453. doi:10.1080/17425247.2017.1393411. Epub 2017 Oct 23. PubMed PMID: 29041861.

 

 

COMUNICACIONS A CONGRESSOS 2020-2019

Implantación de una aplicación informática para el registro de incidencias en un servicio de farmacia.

Castillo Palomares ML, del Estal Jiménez J, Sanjuán Belda A, Pérez Martínez M, Venciana Balsebre L, Canadell Vilarrasa L. 65 Congreso Nacional de la SEFH.

 

Sargramostim, una alternativa de tratamiento en lactantes con neutropenia congénita grave.

Sanjuán Belda A, Martín Marqués M, Rosich del Cacho B, del Estal Jimenez J, Lopez Broseta PA, Jornet Montaña S, Castellarnau Figueras E, Canadell Vilarrasa L. 65 Congreso nacional de la SEFH.

 

Análisis de las reacciones adversas del tratamiento para el COVID-19 y estudio de los factores de riesgo asociados.

del Estal Jiménez J, Sanjuán Belda A, Esteve Pitarch E, López Broseta PA, Mendoza Aguilera M, Roch Ventura MA, Martín Marqués M, Canadell Vilarrasa L. 65 Congreso nacional de la SEFH.

 

Optimización del circuito de dispensacion de quimioterapia parenteral y oral en el paciente hematológico.

del Estal Jiménez J, Vuelta Arce M, Jornet Montaña S, Sanjuán Belda A, Esteve Pitarch E, Martín Marqués M, López Broseta PA, Canadell Vilarrasa L. 65 Congreso nacional de la SEFH.

 

Desarrollo de un protocolo de prescripción de nutrición artificial en neonatología.

del Estal Jiménez j, Martín Marqués M, Albújar Font M, Sanjuán Belda A, López Broseta PA, Esteve Pitarch E, Vuelta Arce M, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Caso clínico: riesgo de cardiotoxicidad por doxorubicina: manejo en la práctica clínica.

del Estal Jiménez J, Vuelta Arce M, Do Nascimento Ferreira J, Sanjuán Belda A, Esteve Pitarch E, López Broseta PA, Martín Marqués M, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Influencia del farmacéutico clínico en la estandarización de preparaciones intravenosos en una unidad de cuidados intensivos.

Esteve Pitarch E, Esteban Reboll F, Sanjuan Belda A, del Estal Jimenez J, Mendoza Aguilera M, López Broseta P, Martin Marques M, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Manejo de los eventos trombóticos en pacientes COVID y determinación de factores asociados.

Sanjuán Belda A, Mendoza Aguilera M, Roch Ventura MA, del Estal Jiménez J, López Broseta PA, Esteve Pitarch E, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Elaboración e implantación de un protocolo de extravasación de fármacos no peligrosos en la unidad neonatal de cuidados intensivos.

Sanjuán Belda A, Martín Marqués M, Otero Vaccarello OM, Albujar Font MM, del Estal Jiménez J, Esteve Pitarch E, López Broseta PA, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Diseño de material de soporte para la prescripción de nutrición artificial en neonatología.

del Estal Jiménez J, Martín Marqués M, Albujar Font MM, Sanjuán Belda A, López Broseta PA, Vuelta Arce M, Canadell Vilarrasa L. 35 congreso nacional de la senpe.

 

Reacondicionamiento de fortificante en cápsulas.

del Estal Jiménez J, Martín Marqués M, Sanjuán Belda A, Albujar Font MM, López Broseta PA, Vuelta Arce M, Canadell Vilarrasa L. 35 ongreso nacional de la SENPE.

 

Desprescripción de la terapia no antirretroviral en pacientes con infección VIH polimedicados.

Mendoza Aguilera M, Peraire Forner J, Moltó Marhuenda J, Roch Ventura MA, Lopez Broseta PA, Esteve Pitarch E, Jornet Montaña S, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Relación entre concentraciones séricas de adalimumab y respuesta clínica en patologías reumáticas.

López Broseta PA, Mendoza Aguilera A, Martín Marqués M, Jornet Montaña S, Vuelta Arce M, del Estal Jiménez J, Sanjuan Belda S, Canadell Vilarrasa L. 65 congreso nacional de la SEFH.

 

Influencia del farmacéutico clínico en la estandarización de preparaciones intravenosas en una unidad de cuidados intensivos.

Esteve-Pitarch E, Esteban-Reboll F, Sanjuán-Belda A, del Estal-Jimenez J, Mendoza-Aguilera M, López-Broseta PA, Martín-Marques M, Canadell-Vilarrasa L. 65 congreso nacional de la SEFH.

 

Levofloxacin 0,05 % eyedrops elaboration: a case of study.

M. Martín Marqués, A. de Dios López, J. del Estal Jiménez, P.A. López Broseta, M.A. Roch Ventura, A. Sanjuan Belda, S. Jornet Montaña, E. Esteve Pitarch, M. Vuelta Arce, M. Mendoza Aguilera, L. Canadell Vilarrasa. 25 EAHP congress

 

Analysis of usage of direct acting antivirals for the treatment of hepatitis C.

M.A. Roch Ventura, J. del Estal Jiménez, A. Sanjuan Belda, M. Mendoza Aguilera, P.A. López Broseta, E. Esteve Pitarch, M. Martín Marqués, S. Jornet Montaña, M. Vuelta Arce, L. Canadell Vilarrasa. 25 EAHP congress

 

 

Libro de casos clínicos de residentes en Farmacia Hospitalaria. Curso de formación continuada 2018-2019 de la Sociedad Catalana de Farmacia Clínica (SCFC). Caso clínico 7: ENFERMEDAD DE CROHN REFRACTARIA EN EL PACIENTE JOVEN.

Noviembre de 2020. Jorge del Estal Jiménez y Anna de Dios López. Sociedad Catalana de Farmacia Clinica.

 

 

Resultats preliminars d’una estratègia d’actuació assistencial al Centre de Drogodependències (CAS) de Tarragona, pel tractament dels individus amb l’hepatitis crònica C (HCC) addictes a drogues en teràpia amb agonistes opiacis (TAO).

Magdalena Vilanova Serra; Adrià Rodríguez-Castellano; Maria Assumpció Sendra Soler; María Ángeles Roch Ventura; Silvia Montoliu Llopis; Albert Pardo Balteiro; Inés Sáenz de Miera Olivera; Maria Antonia Llaberia Pedret; Patricia Méndez Sierra; Joan Carles Quer Boniquet. XXX Congrés de la Societat Catalana de Digestologia.

Dra. Laura Canadell Vilarrasa

lcanadell.hj23.ics@gencat.cat
Servei de Farmàcia. Hospital Universitari de Tarragona Joan XXIII
C/ Doctor Mallafrè Guasch, 4, 43005 Tarragona